By Professor David Lawson Morris

Conference Presentations

Bahrami-B F; Pourgholami MH; Morris DL, 2014, 'A NOVEL AMINOACETONITRILE DERIVATIVE, MONEPANTEL (AAD-1566) INHIBITS OVARIAN CANCER CELL GROWTH THROUGH SUPPRESSION MTORC1 AND INDUCTION OF AUTOPHAGY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bahrami B F; Morris DL; Pourgholami MH, 2014, 'MONEPANTEL (AAD-1566) INHIBITS MAMMALIAN TARGET OF RAPAMYCIN SIGNALING THROUGH INHIBITION OF MAJOR COMPONENTS IN THE MTOR AXIS AND INDUCTION OF AUTOPHAGY IN OVARIAN CANCER CELLS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500280&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ataie-Kachoie P; Morris DL; Pourgholami MH, 2014, 'Minocycline regulates hypoxia-inducible factor-1 alpha expression through the induction of its degradation in ovarian cancer: in vitro and in vivo studies', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-3689

Sugarbaker PH; Morris DL; Piso P; Esquivel J, 2011, 'Case Presentations', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011

Morris DL, 2011, 'Combination of liver resection with regional chemotherapy and/or radiofrequency ablation', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011

Saxena A; Liauw W; Chu F; Morris DL, 2011, 'Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011

Morris DL, 2011, 'How to start PC program', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011

Morris DL, 2011, 'Selection criteria for surgical treatment of liver metastases', presented at 5th International Symposium on Abdominal Metastatic Cancer, Regensburg, Germany, 04 July 2011 - 05 July 2011

Saxena A; Chua TC; Morris DL, 2011, 'Liver-Directed therapy as treatment of hepatic progression following surgical extirpaton of neuroendocrine neoplasm hepatic metastasis.', presented at Annual Cancer Symposium Society of Surgical Oncology, San Antonio, Texas, USA, 03 March 2011 - 07 March 2011

Saxena A; Chua TC; Zhao J; Morris DL, 2011, 'Optimizing the surgical effort in patients with advanced neuroendocrine tumor hepatic metastases by combining hepatic resection with ablation: A critical analysis of 40 patients.', presented at Annual Cancer Symposium Society of Surgical Oncology, San Antonio, Texas, USA, 03 March 2011 - 07 March 2011

Pelz J; Chua TC; Esquivel J; Stojadinovic A; Doerfer J; Morris DL; Germer CT; Kerscher A, 2010, 'Evaluation of best supportive care and systemic chemotherapy as treatment for peritoneal carcinomatosis of colorectal origin', presented at 7th International Workshop on Peritoneal Surface Malignancy, Uppsala, Sweden, 08 September 2010 - 10 September 2010

Morris DL, 2010, 'Management of high grade PMP', presented at 7th International Workshop on Peritoneal Surface Malignancy, Uppsala, Sweden, 08 September 2010 - 10 September 2010

Saxena A; Morris DL, 2010, 'Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: A 19-year experience form an Established Australian Hepatobiliary', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010

Morris DL, 2010, 'Evaluation of the effectiveness of a novel anaesthetic protocol in reducing massive blood transfusion during cytoreductive surgery: Can early and aggressive administration of fresh frozen plasma combined with restrictive fluid resuscitation really work?', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010

Morris DL, 2010, 'Progression and survival results following radical hepatic metastasectomy of advanced neuroendocrine tumor supports and aggressive surgical approach', presented at Annuals Scientific Congress, Perth Convention Exhibition Centre, Perth, Australia, 04 May 2010 - 07 May 2010

Pourgholami MH; Cai YZ; Badar S; Poruchynsky MS; Morris DL, 2010, 'Down-regulation of tumoral hypoxia-inducible factor-1 alpha expression in OVCAR-3 tumors by albendazole', presented at AACR 101st Annual Meeting, Walter E.Washington Convention Centre, Washington DC, 17 April 2010 - 21 April 2010

Chua TC; Saxena A; Chu F; Liauw WS; Kokandi A; Zhao J; Morris DL, 2010, 'Clinicopathological determinants of survival after hepatic resection on hepatocellular cacinoma in 97 patients - Experience from an Australia Hepatobiliary Unit', presented at 63rd Annual Cancer Symposium, Society of Surgical Oncology, St. Louis, Missouri, 03 March 2010 - 07 March 2010

Chua TC; Chu F; Butler P; Quinn RJ; Glenn DW; Morris DL, 2010, 'Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma', presented at 63rd Annual Cancer Symposium, Society of Surgical Oncology, St. Louis, Missouri, 03 March 2010 - 07 March 2010

Morris DL, 2009, 'Peritonectomy for colorectal cancer, pseudomyxoma peritonei peritoneal mesothelioma and ovarian cancer', presented at 5th Scientific Conference for Saudi General Surgery Society, King Fahad Medical Research Centre, King Abdulaziz University Jeddah, 19 October 2009 - 21 October 2009

Chua TC; Liauw WS; Saxena A; Chu F; Glenn DW; Chai A; Morris DL, 2009, 'Systematic review of randomized and nonrandomized trials on the clinical efficacy and safety of neoadjuvant transarterial chemoembolization (TACE)for resectable hepatocellular carcinoma', presented at International Liver Cancer Association 3rd Annual Conference (ILCA), Milan, Italy, 04 September 2009 - 06 September 2009

Maunic M; Morris DL, 2009, 'Colon cancer', presented at Medical Legal Conference, Amora Hotel, Jamison Street, Sydney Australia, 24 July 2009

Saxena A; Morris DL, 2009, 'Preoperative and operative risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei', presented at Royal Australasian College of Surgeons Annual Scientific Congress, Brisbane, Australia, 06 May 2009

Saxena A; Morris DL, 2009, 'Risk factors for massive blood transfusion after cytoreductive surgery and perioperative intraperitoneal chemotherapy', presented at Royal Australasian College of Surgeons Annual Scientific Congress, Brisbane, Australia, 06 May 2009

Morris DL, 2009, 'Peritonectomy role in advanced/recurrent ovarian cancer', presented at 1st International Conference & Workshop on Up to Date Obstetrics & Gynecology, King Fahad Medical City, Riyadh, 13 April 2009 - 15 April 2009

Morris DL, 2009, 'Cytoreductive surgery', presented at National Symposium on Update of Oncology & Lymphoma, King Fahad Specialist Hospital Buraidah, Al Qassim & Prince Faisal Bin Bandar Cancer Centre, 08 April 2009

Chua TC; Yao P; Akhter J; Young L; Samaraweera U; Yan TD; Morris DL, 2009, 'Differential expression of Ki-67, estrogen receptor, and progesterone receptor between genders in peritoneal mesothelioma: An immunohistochemistry study that provides a plausible explanation for the better prognosis in females?', presented at Annual Cancer Symposium Society of Surgical Oncology, Phoenix Arizona, USA, 04 March 2009 - 08 March 2009

Back to profile page